Back to Newsroom
Back to Newsroom

Kaskela Law LLC Announces Stockholder Investigation of LogicBio Therapeutics, Inc. - LOGC

Saturday, 31 October 2020 08:00 AM

Kaskela Law LLC

Topic:
Lawsuits

PHILADELPHIA, PA / ACCESSWIRE / October 31, 2020 / Kaskela Law LLC, announces that it is investigating LogicBio Therapeutics, Inc. ("LogicBio") (NASDAQ:LOGC) on behalf of the company's stockholders.

The investigation seeks to determine whether LogicBio and/or the company's officers and directors have violated the securities laws or breached their fiduciary duties and whether LogicBio investors have been harmed as a result of such actions.

LogicBio stockholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 - 1585 or (888) 715 - 1740, or via email at [email protected], to discuss this investigation and their legal rights and options. Additional information may also be found at http://kaskelalaw.com/case/logicbio-therapeutics-inc/.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC, please visit www.kaskelalaw.com.

CONTACT:
D. Seamus Kaskela, Esq.

KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258-1585
(888) 715-1740
[email protected]
www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

SOURCE: Kaskela Law LLC

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: